Compare QGEN & VIAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QGEN | VIAV |
|---|---|---|
| Founded | 1986 | 1923 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 9.0B |
| IPO Year | 1998 | 1996 |
| Metric | QGEN | VIAV |
|---|---|---|
| Price | $43.27 | $35.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $45.76 | $32.66 |
| AVG Volume (30 Days) | 3.1M | ★ 4.4M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | ★ 7.17% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,518,300,000.00 |
| Revenue This Year | $8.18 | $37.78 |
| Revenue Next Year | $5.71 | $10.64 |
| P/E Ratio | $24.01 | ★ N/A |
| Revenue Growth | N/A | ★ 40.03 |
| 52 Week Low | $32.53 | $11.43 |
| 52 Week High | $57.82 | $60.43 |
| Indicator | QGEN | VIAV |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 39.75 |
| Support Level | $41.14 | $34.83 |
| Resistance Level | $44.22 | $35.61 |
| Average True Range (ATR) | 1.09 | 2.04 |
| MACD | -0.07 | -0.39 |
| Stochastic Oscillator | 67.64 | 0.00 |
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).
Viavi Solutions Inc is a world-wide leader in test and measurement and optical technologies. Its test and measurement, and resilient Position, Navigation and Timing (PNT) solutions enable and secure critical infrastructure ranging from data center ecosystems and communication networks to military, aerospace, railway and first responder communications. In addition, it develop and advance technologies used in high-volume optical applications across anti-counterfeiting, consumer electronics, aerospace, industrial and automotive end markets. The company's segments are Network and Service Enablement (NSE); and Optical Security and Performance Products (OSP). Majority of revenue comes from NSE segment. It has presence in Americas, Asia-Pacific, and EMEA. Majority of revenue is from America.